Arcus Biosciences's total assets for Q1 2026 were $997.00M, a decrease of -12.47% from the previous quarter. RCUS total liabilities were $473.00M for the fiscal quarter, a -6.89% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.